- A nurse warns that weight-loss injections like Mounjaro are prescribed without crucial blood tests, risking pancreatitis, organ failure, and death.
- UK regulators are investigating more than 560 reports of pancreas inflammation and ten deaths linked to GLP-1 agonist drugs.
- Mandatory blood screening could identify high-risk patients, but corporate providers prioritize profits over safety, skipping safeguards.
- Post-market data reveals severe risks, including contraceptive failure, muscle wasting, and blindness, yet manufacturers downplay dangers.
- Experts demand stricter regulations, pre-screenings, and holistic obesity care instead of profit-driven pharmaceutical shortcuts.
A medical whistleblower has exposed a life-threatening oversight in the booming weight loss injection industry, revealing that thousands of patients are being prescribed potent GLP-1 agonist drugs like Mounjaro without critical blood tests that could prevent pancreatitis, sepsis, and fatal organ failure.
As UK regulators investigate more than 560 reports of pancreas inflammation and ten deaths linked to these “miracle” injections, frontline healthcare workers are demanding immediate reforms to protect vulnerable patients from Big Pharma’s reckless profit-driven protocols.
Hellbound and Down 